These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 15811136
1. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. de Boer H, Verschoor L, Ruinemans-Koerts J, Jansen M. Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136 [Abstract] [Full Text] [Related]
7. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation. Holbrook JM, Cohen PG. South Med J; 2003 Jun; 96(6):544-7. PubMed ID: 12938779 [Abstract] [Full Text] [Related]
13. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Lanfranco F, Zitzmann M, Simoni M, Nieschlag E. Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966 [Abstract] [Full Text] [Related]
14. Aromatase activity after a short-course of letrozole administration in adult men at sea level and at high altitude (with or without excessive erythrocytosis). Gonzales GF, Tapia V, Gasco M, Gonzales-Castañeda C. Horm Metab Res; 2012 Feb; 44(2):140-5. PubMed ID: 22274717 [Abstract] [Full Text] [Related]
19. Evidence for hypogonadism in massively obese males due to decreased free testosterone. Kley HK, Deselaers T, Peerenboom H. Horm Metab Res; 1981 Nov; 13(11):639-41. PubMed ID: 7198085 [Abstract] [Full Text] [Related]
20. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido). Moisey R, Swinburne J, Orme S. Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]